跳至主要内容
临床试验/NCT02392091
NCT02392091已完成不适用

Renal Tubular Acidosis is Highly Prevalent in Critically Ill Patients

Medical University of Vienna0 个研究点目标入组 100 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
主要终点
renal-tubular acidosis

研究概览

简要总结

The aim of this study was to investigate the prevalence, type, and possible risk factors of RTA in critically ill patients using a physical-chemical approach.

详细描述

Hyperchloremic acidosis is frequent in critically ill patients. Renal tubular acidosis (RTA) may contribute to acidemia in the state of hyperchloremic acidosis, but the prevalence of RTA has never been studied in critically ill patients. Therefore, we aimed to investigate the prevalence, type, and possible risk factors of RTA in critically ill patients using a physical-chemical approach.

This prospective, observational trial was conducted in a medical ICU of a university hospital. 100 consecutive critically ill patients at the age ≥18, expected to stay in the ICU for ≥24h, with the clinical necessity for a urinary catheter and the absence of anuria were included.

Base excess subset calculation based on a physical-chemical approach on the first seven days after ICU admission was used to compare the effects of free water, chloride, albumin, and unmeasured anions on the standard base excess. Calculation of the urine osmolal gap (UOG) - as an approximate measure of the unmeasured urine cation ammonium - served as determinate between renal and extra-renal bicarbonate loss in the state of hyperchloremic acidosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • admitted to the medical ICU of the Div. of Gastroenterology & Hepatology of the Medical University of vienna
  • expectancy to stay in the ICU ≥24hours
  • clinical necessity for a urinary catheter

排除标准

  • 未提供

结局指标

主要结局

renal-tubular acidosis

时间窗: up to 7 days after ICU admission

Diagnosis of renal-tubular acidosis in critically ill patients within 7 days after ICU admission.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard Brunner, MD

Dr

Medical University of Vienna

相似试验